Expression of growth differentiation factor 15 is positively correlated with histopathological malignant grade and in vitro cell proliferation in oral squamous cell carcinoma

Oral Oncology

Volumn 45, Issue 7, 2009, Pages 627-632

  Zhang, Lei ^a   Yang, Xiao ^a   Pan, Hong ya ^a   Zhou, Xiao jian ^a   Li, Jiang ^a   Chen, Wan tao ^a   Zhong, Lai ping ^a   Zhang, Zhi yuan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Growth differentiation factor 15; Oral squamous cell carcinoma; Pathological differentiation grade; siRNA interference

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; MESSENGER RNA; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUTH CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; RNA, SMALL INTERFERING;

EID: 67549138951     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.07.017     Document Type: Article

References (28)

1. Kademani D. Oral cancer. Mayo Clin Proc 82 (2007) 878-887
2. Petersen P.E. The World Oral Health Report 2003: continuous improvement of oral health in the 21st century-the approach of WHO Global Oral Programme. Community Dent Oral Epidemiol 31 Suppl. (2003) 3-23
3. Sdek P., Zhang Z.Y., Cao J., Pan H.Y., Chen W.T., and Zheng J.W. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. Int J Oral Maxillofac Surg 35 (2006) 653-657
4. Zhong L.P., Pan H.Y., Zhou X.J., Ye D.X., Zhang L., Yang X., et al. Characteristics of a cancerous cell line, HIOEC-B(a)P-96, induced by benzo(a)pyrene from human immortalized oral epithelial cell line. Arch Oral Biol 53 (2008) 443-452
5. Chen S.J., Karan D., and Johansson S.L. Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells. Prostate 67 (2007) 557-571
6. Hromas R., Hufford M., Sutton J., Xu D., Li Y., and Lu L. PLAB, a novel placental bone morphogenetic protein. Biochim Biophys Acta 1354 (1997) 40-44
7. Tan M., Wang Y., Guan K., and Sun Y. PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc Natl Acad Sci USA 97 (2000) 109-114
8. Bootcov M.R., Bauskin A.R., Valenzuela S.M., Moore A.G., Bansal M., He X.Y., et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-b superfamily. Proc Natl Acad Sci USA 94 (1997) 11514-11519
9. Fairlie W.D., Moore A.G., Bauskin A.R., Russell P.K., Zhang H.P., and Breit S.N. MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 65 (1999) 2-5
10. Baek S.J., Kim K.S., Nixon J.B., Wilson L.C., and Eling T.E. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 59 (2001) 901-908
11. Welsh J.B., Sapinoso L.M., Su A.I., Kern S.G., Wang-Rodriguez J., Moskaluk C.A., et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61 (2001) 5974-5978
12. Lee D.H., Yang Y., Lee S.J., Kim K.Y., Koo T.H., Shin S.M., et al. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Cancer Res 63 (2003) 4648-4655
13. Karan D., Chen S.J., Johansson S.L., Singh A.P., Paralkar V.M., Lin M.F., et al. Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochem Biophys Res Commun 305 (2003) 598-604
14. Brown D.A., Ward R.L., Buckhaults P., Liu T., Romans K.E., Hawkins N.J., et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 9 (2003) 2642-2650
15. Selander K.S., Brown D.A., Sequeiros G.B., Hunter M., Desmond R., Parpala T., et al. Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases. Cancer Epidemiol Biomarkers Prev 16 (2007) 532-537
16. Liu T., Bauskin A.R., Zaunders J., Brown D.A., Pankhurst S., Russell P.J., et al. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 63 (2003) 5034-5040
17. Lambert J.R., Kelly J.A., Shim M., Huffer W.E., Nordeen S.K., Baek S.J., et al. Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth. J Cell Physiol 208 (2006) 566-574
18. Shim M., and Eling T.E. Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells. J Biol Chem 280 (2005) 18636-18642
19. Ackerstaff E., Gimi B., Artemov D., and Bhujwalla Z.M. Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line. Neoplasia 9 (2007) 222-235
20. Zhong L.P., Chen W.T., Zhan C.P., and Zhang Z.Y. Increased CK19 expression correlated with pathological differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 (2007) 377-384
21. Zhong L.P., Zhang C.P., Li J., Chen W.T., and Zhang Z.Y. Increase of Cyfra 21-1 concentration in saliva from oral squamous cell carcinoma patients. Arch Oral Biol 52 (2007) 1079-1087
22. Sobin L.H., and Wittekind C.H. International Union Against Cancer (UICC) TNM classification of malignant tumours. 6th ed. (2002), Wiley-Liss, New York p. 22-6
23. Barnes L., Eveson J.W., and Reichart P. World Health Organization classification of tumours, pathology and genetics of head and neck tumours (2005), IARC Press, Lyon p. 168-75
24. Kenneth J.L., and Thomas D.S. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 25 (2001) 402-408
25. Zhong L.P., Li J., Zhang C.P., Zhu H.G., Sun J., and Zhang Z.Y. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Arch Oral Biol 52 (2007) 740-747
26. de Wit N.J., Rijntjes J., Diepstra J.H., van Kuppevelt T.H., Weidle U.H., Ruiter D.J., et al. Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. Br J Cancer 92 (2005) 2249-2261
27. Koopmann J., Buckhaults P., Brown D.A., Zahurak M.L., Sato N., Fukushima N., et al. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res 10 (2004) 2386-2392
28. Ichikawa T., Suenaga Y., Koda T., Ozaki T., and Nakagawara A. TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation. Oncogene 27 (2008) 409-420